Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 9 (HMGB3P9) is a processed pseudogene (also called a retrogene) of the parental gene HMGB3 (high mobility group box 3)[1][3][5]. It is found in the human genome as a nonfunctional, intronless copy derived by retrotransposition[5][7][10]. Unlike protein-coding HMGB genes, this pseudogene is not known to produce a functional RNA or protein and does not have an established role as a therapeutic target, biomarker, or in human disease[3][1][5]. There is no evidence that HMGB3P9 is transcribed or otherwise functional, and it is not considered a druggable target or pathologically relevant locus in the current biomedical literature[3][1][4][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 9 (HMGB3P9).